Nuvalent (NUVL) Change in Account Payables (2020 - 2026)

Nuvalent (NUVL) reported Change in Account Payables of -$7.7 million for Q1 2026, down 136.71% on a YoY basis from $20.9 million in Q1 2025, and down 198.39% quarter-over-quarter from $7.8 million in Q4 2025.

Nuvalent (NUVL) Change in Account Payables (2020 - 2026) Analysis & Trends

Nuvalent has reported Change in Account Payables for 7 years, with the latest figure at -$7.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables fell 136.71% year-over-year to -$7.7 million; the trailing twelve-month figure through Mar 2026 stood at -$4.0 million (down 131.55% YoY), and the FY2025 full-year result was $24.6 million, up 707.53% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$7.7 million, down from $7.8 million in the prior quarter.
  • The five-year high for Change in Account Payables was $20.9 million in Q1 2025, with the low at -$12.8 million in Q2 2025.
  • Historically, Change in Account Payables has averaged $1.1 million across 5 years, with a median of $1.4 million in 2022.
  • Annual changes were most pronounced in 2023 — Change in Account Payables jumped 872.48% — and 2024, when it slumped 1996.45%.
  • Nuvalent's Change in Account Payables stood at $2.5 million in 2022, then tumbled by 120.4% to -$507000.0 in 2023, then tumbled by 1996.45% to -$10.6 million in 2024, then soared by 173.52% to $7.8 million in 2025, then tumbled by 198.39% to -$7.7 million in 2026.
  • The last three Change in Account Payables figures came in at -$7.7 million (Q1 2026), $7.8 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -3.26 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 35.60 Mn
9 Abivax 91.71 Bn 91.71 Bn - -9.42 Mn
10 Nuvalent 9.70 Bn 9.70 Bn - -7.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.69 Mn
Mar 31, 2026 -7.69 Mn
Dec 31, 2025 7.81 Mn
Dec 31, 2025 7.81 Mn
Sep 30, 2025 8.67 Mn
Sep 30, 2025 8.67 Mn
Jun 30, 2025 -12.82 Mn
Jun 30, 2025 -12.82 Mn
Mar 31, 2025 20.94 Mn
Mar 31, 2025 20.94 Mn
Dec 31, 2024 -10.63 Mn
Dec 31, 2024 -10.63 Mn
Sep 30, 2024 8.45 Mn
Sep 30, 2024 8.45 Mn
Jun 30, 2024 -5.99 Mn
Jun 30, 2024 -5.99 Mn
Mar 31, 2024 4.12 Mn
Mar 31, 2024 4.12 Mn
Dec 31, 2023 -507,000.00
Dec 31, 2023 -507,000.00